AMA-Manatt Profiles in Leadership 2022
“ The fight to end the nation’s overdose epidemic and restore compassionate care: Profiles in leadership .” Read more how a select group of physicians, policymakers and patient advocates exemplify[…]
2022 Overdose Epidemic Report
The American Medical Association Substance Use and Pain Care Task Force continues to advance evidence-based recommendations for policymakers and physicians to help end the nation’s drug-related[…]
AMA-Manatt 2024: Improving Access to Care Pregnant Parenting People with SUD
The American Medical Association (AMA) and Manatt have developed recommendations for policymakers to improve access to care for pregnant and postpartum people with opioid use disorder, focusing[…]
The AMA and Manatt Health 2022 State Toolkit
The AMA and Manatt Health 2022 State Toolkit identifies more than 400 state laws, regulations, policy guidance and other select national actions being implemented to help end the nation’s drug[…]
AMA Opioid Task Force 2020 Progress Report
Sharp reductions in prescription opioid supply, continued increases in PDMP use, but staggering increase in fatalities involving illicit opioids, methamphetamine, heroin and cocaine were demonstrated[…]
AMA Opioid Task Force 2019 Progress Report
The 2019 progress report highlights physician action and the immediate need for policymakers to focus on removing barriers to evidence-based treatment.